Cargando…

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience

Background: With increasing survival rates after hematopoietic stem cell transplantation (HSCT), it has become important to evaluate methods of improving patients’ quality of life. Most female patients of childbearing age experience premature ovarian failure after transplantation, which results in d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Jeonghoon, Han, Je-Ho, Kang, Moo-Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207968/ http://dx.doi.org/10.1210/jendso/bvaa046.030

Ejemplares similares

OR13-03 Understanding Why Older People with Low Trauma Fractures Die Prematurely
por: Tran, Thach, et al.
Publicado: (2020)

OR29-03 Social Isolation Stress Leads To Bone Loss In Adult Male, But Not Female, C57BL/6J Mice
por: Mountain, Rebecca, et al.
Publicado: (2023)

OR03-5 Fractures during Bisphosphonate Therapy after Orthotopic Liver Transplantation: Incidence and Predictors
por: Bégin, Marie-Josée, et al.
Publicado: (2019)

THU440 A Case Of Osteomalacia In A Young Adult Female With Premature Ovarian Insufficiency
por: Kasimoglu, Ismail Hakki, et al.
Publicado: (2023)

OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
por: Lo, Joan, et al.
Publicado: (2019)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

OR03-05 Cinacalcet Acts As A Spatially Biased Allosteric Modulator To Enhance CaSR Signaling From Endosomal Membranes
por: Wyatt, Rachael, et al.
Publicado: (2023)

OR29-02 Natural Language Processing of Radiology Reports Improves Identification of Patients with Fracture
por: Kolanu, Nithin, et al.
Publicado: (2020)

OR29-01 Deleting Salt Inducible Kinases In Osteoprogenitor Cells Increases Trabecular Bone
por: Papaioannou, Garyfallia, et al.
Publicado: (2023)

OR29-02 Energy Deficient Osteoblasts Inefficiently Mineralize Developing Bone In Sheep With Hypophosphatasia
por: Clarence Bertels, Joshua, et al.
Publicado: (2023)

OR29-06 Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome
por: Carpenter, Thomas O, et al.
Publicado: (2020)

OR03-3 High Spermidine Level was Associated with Increased Risk of Osteoporotic Fracture: A 10-Year Prospective Longitudinal Study in a Community-Based Cohort
por: Kong, Sung Hye, et al.
Publicado: (2019)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

OR29-07 A Novel Estimate of Creatinine Excretion to Determine Adequacy of 24-Hr Urine Collection
por: Kondapalli, Ananya V, et al.
Publicado: (2020)

OR29-04 TGFβ Regulates Bone Perilacunar/Canalicular Remodeling in a Sexually Dimorphic Manner
por: Dole, Neha, et al.
Publicado: (2020)

OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023)

OR29-04 Vitamin D Signaling Prevents Glucocorticoid-Induced Musculoskeletal Tissue Loss And Cardiac Dysfunction By Targeting The Atrogene Pathway
por: Sato, Amy, et al.
Publicado: (2023)

OR03-6 Tibial and Radial Bone Structure as Assessed by HRpQCT May Explain Differences in Peripheral Skeletal Integrity and Fracture Risk Across the Weight Spectrum That Cannot Be Explained by Areal BMD Alone
por: Schorr, Melanie, et al.
Publicado: (2019)

MON-537 Fusion of Parathyroid Hormone to Growth Hormone Binding Protein Delays Clearance Whilst Retaining Biological Activity
por: Wilkinson, Ian, et al.
Publicado: (2019)

OR29-01 Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial
por: Perwad, Farzana, et al.
Publicado: (2020)

OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629)
por: Ilana Gafni, Rachel, et al.
Publicado: (2023)

OR29-05 Sarcopenia, Low Bone Mineral Density And Hidden Obesity In Young Adult Men Living With HIV (MLWH): Prevalence And Relationship With Sex Steroids
por: De Vincentis, Sara, et al.
Publicado: (2023)

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis
por: Zhou, Ziyue, et al.
Publicado: (2021)

SUN-499 An Unusual Case of a Misleading Elevated Parathyroid Hormone Level
por: Burks, Margaret, et al.
Publicado: (2019)

RF30 | PSAT135 Rare Case of Hypercalcemia Mediated by an Ectopic Parathyroid Hormone (PTH), and Parathyroid Hormone-Related Peptide (PTHrP) Co-Secretion Secondary to Metastatic Cervical Carcinoma
por: Gaballa, Salem, et al.
Publicado: (2022)

MON-506 Escalating Vitamin D Requirements as the Harbinger of Liver Failure: A Case of Recalcitrant Vitamin D Deficiency Resolved by Liver Transplant
por: Stevenson, Kristin, et al.
Publicado: (2019)

ODP110 Parathyroid Hormone Independent Hypercalcaemia Secondary to Granulomatous Inflammation: Could This Be Melioidosis?
por: Grace, Samuel, et al.
Publicado: (2022)

SAT-387 Testing for Parathyroid Hormone: Performances of a Novel Fully Chemiluminescent Automated Assay
por: Gruson, Damien, et al.
Publicado: (2020)

SAT191 Primary Hyperparathyroidism With Low-Normal Parathyroid Hormone Levels: Phosphorus Can Be The Key
por: He, Diana, et al.
Publicado: (2023)

Methadone Maintenance Treatment, Sex Hormones and Low Bone Density in a Population of Injection Drug Users
por: Wehbeh, Leen, et al.
Publicado: (2021)

SAT-495 1-α-Hydroxylase Activity-Mediated Hypercalcemia Associated with Ovarian Dysgerminoma
por: Subbu, Karthik, et al.
Publicado: (2019)

Treatment-Resistant Hypercalcemia Secondary to Ectopic PTH Hypersecretion From Disseminated Ovarian Cancer
por: Balinski, Alexander M, et al.
Publicado: (2021)

RF06 | PSAT152 Associations between Bone Mass, Hormone Levels and Body Composition in Postmenopausal Women
por: Fighera, Tayane, et al.
Publicado: (2022)

THU415 Trabecular Bone Score In Hospitalized Patients With Heart Failure
por: Bandeira, Francisco, et al.
Publicado: (2023)

MON-536 Improving the Accuracy and Reliability of Parathyroid Hormone Measurements by Establishing a Mass Spectrometric Reference Measurement Procedure
por: Ulmer, Candice, et al.
Publicado: (2019)

SUN-348 Growth Hormone Replacement in Adults During 8 Years Leads to Sustained Increase in Bone Mineral Density
por: Payer, Juraj, et al.
Publicado: (2020)

The Role of Thyroid Hormone 3,3 ‘, 5 - Triiodothyronine (T3) in the Expression of Osteocalcin and Lipocalin 2 (LCN2) in Osteoblasts
por: de Camargo Andrade, Amanda Fantini, et al.
Publicado: (2021)

ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
por: Torres, Marta Isabel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l6o8o801a6m9vncg9pi9mjvb7p